RETINAL–CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2

Purpose: To investigate the deep retinal vascular changes potentially present in macular telangiectasis Type 2 (MacTel 2) with projection resolved optical coherence tomography angiography including volume rendering. Methods: Retrospective consecutive evaluation of patients with MacTel 2 in a community-based retinal referral practice with a comprehensive ophthalmologic examination to include optical coherence tomography and projection-resolved optical coherence tomography angiography with volume rendering. Main outcome measures were the characterization of vessel presence and anatomical arrangement in the outer retina. Results: There were 26 eyes of 13 patients with a mean age of 64.9 (±11.3) years, and 6 were men. The mean visual acuity was logMAR 0.4 (Snellen equivalent 20/50). No eye had signs of choroidal neovascularization or exudation. Focal hyperpigmentation was seen in 13 (50%) and right-angle veins in 17 (65%) eyes. Retinal–choroidal anastomoses were seen in 17 (65%) eyes. These anastomoses typically occurred in multiple clusters of small vessels. The presence of anastomoses was associated with pigment (P < 0.001), although the anastomoses did not necessarily colocalize with the pigment, and right-angle veins (P < 0.001), which were found in every eye with a retinal–choroidal anastomosis. Conclusion: Retinal–choroidal anastomoses were commonly observed in eyes with MacTel 2 using projection-resolved optical coherence tomography angiography. One animal model for MacTel 2 uses very low-density lipoprotein receptor mutant mice and shows multiple retinal–choroidal anastomoses in the disease pathogenesis as well. These findings suggest MacTel 2 is more than just a neurodegenerative disease with secondary vascular abnormalities, as the choroid may be involved in the disease process.

[1]  Woo June Choi,et al.  Tail artifact removal in OCT angiography images of rodent cortex , 2017, Journal of biophotonics.

[2]  Jian-xing Ma,et al.  Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration , 2017, Investigative ophthalmology & visual science.

[3]  Lawrence A. Yannuzzi,et al.  VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MACULAR TELANGIECTASIA TYPE 2 , 2017, Retina.

[4]  Melanie Bahlo,et al.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2 , 2017, Nature Genetics.

[5]  David Huang,et al.  Projection-resolved optical coherence tomographic angiography. , 2016, Biomedical optics express.

[6]  R. Spaide,et al.  VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY , 2015, Retina.

[7]  Richard F Spaide,et al.  Volume-Rendering Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2. , 2015, Ophthalmology.

[8]  L. Yannuzzi,et al.  POSSIBLE CHOROIDAL NEOVASCULARIZATION IN MACULAR TELANGIECTASIA TYPE 2 , 2015, Retina.

[9]  Ruikang K. Wang,et al.  SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2 , 2015, Retina.

[10]  Ruikang K. Wang,et al.  Minimizing projection artifacts for accurate presentation of choroidal neovascularization in OCT micro-angiography. , 2015, Biomedical optics express.

[11]  Richard F Spaide,et al.  Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. , 2015, JAMA ophthalmology.

[12]  Meidong Zhu,et al.  Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. , 2013, Ophthalmology.

[13]  Emily Y. Chew,et al.  Macular telangiectasia type 2 , 2013, Progress in Retinal and Eye Research.

[14]  Lois E. H. Smith,et al.  Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. , 2011, Investigative ophthalmology & visual science.

[15]  R. Guymer,et al.  Perifoveal müller cell depletion in a case of macular telangiectasia type 2. , 2010, Ophthalmology.

[16]  Oscar Yanes,et al.  Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. , 2009, The Journal of clinical investigation.

[17]  H. Scholl,et al.  ABNORMAL MACULAR PIGMENT DISTRIBUTION IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA , 2008, Retina.

[18]  T. Berendschot,et al.  Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. , 2008, Investigative ophthalmology & visual science.

[19]  B. Chang,et al.  Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. , 2008, Investigative ophthalmology & visual science.

[20]  Martin Friedlander,et al.  MOUSE MODEL OF SUBRETINAL NEOVASCULARIZATION WITH CHOROIDAL ANASTOMOSIS , 2003, Retina.

[21]  B. Blodi,et al.  Idiopathic juxtafoveolar retinal telangiectasis , 1993 .

[22]  C. Payne,et al.  Chorioretinal anastomoses in age-related macular degeneration. , 1989, Annals of ophthalmology.

[23]  P. Liao,et al.  Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment , 1987, The Yale Journal of Biology and Medicine.

[24]  D. Archer,et al.  Contusional eye injuries: retinal and choroidal lesions. , 1983, Australian journal of ophthalmology.

[25]  B. Doft Choroidoretinal vascular anastomosis. , 1983, Archives of ophthalmology.

[26]  J. Gass,et al.  Idiopathic juxtafoveolar retinal telangiectasis. , 1982, Archives of ophthalmology.

[27]  M. Slusher,et al.  Choroidoretinal vascular anastomoses. , 1980, American journal of ophthalmology.

[28]  M. Goldberg,et al.  Chorioretinal vascular anastomoses resulting from photocoagulation in cynomolgus monkeys. , 1980, Ophthalmic surgery.